Lpl Financial LLC Aerie Pharmaceuticals Inc Transaction History

Lpl Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.02 - $13.33 $186,970 - $355,031	-26,634 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.32 - $16.63 $21,643 - $31,796	1,912 Added 7.73%	26,634 $304,000
Q2 2021 Aug 13, 2021	BUY	$15.16 - $18.97 $16,433 - $20,563	1,084 Added 4.59%	24,722 $396,000
Q1 2021 May 14, 2021	BUY	$13.12 - $20.9 $132,013 - $210,295	10,062 Added 74.12%	23,638 $422,000
Q4 2020 Feb 12, 2021	SELL	$9.12 - $14.49 $2,872 - $4,564	-315 Reduced 2.27%	13,576 $183,000
Q3 2020 Nov 09, 2020	BUY	$10.46 - $14.46 $3,629 - $5,017	347 Added 2.56%	13,891 $163,000
Q2 2020 Aug 13, 2020	BUY	$12.0 - $16.13 $22,320 - $30,001	1,860 Added 15.92%	13,544 $200,000
Q1 2020 May 14, 2020	BUY	$11.84 - $25.52 $615 - $1,327	52 Added 0.45%	11,684 $158,000
Q4 2019 Feb 14, 2020	BUY	$17.72 - $25.1 $206,119 - $291,963	11,632 New	11,632 $281,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.